2022
DOI: 10.1002/adhm.202202123
|View full text |Cite
|
Sign up to set email alerts
|

Nanostructured‐Based Optical Readouts Interfaced with Machine Learning for Identification of Extracellular Vesicles

Abstract: Extracellular vesicles (EVs) are shed from cancer cells into body fluids, enclosing molecular information about the underlying disease with the potential for being the target cancer biomarker in emerging diagnosis approaches such as liquid biopsy. Still, the study of EVs presents major challenges due to their heterogeneity, complexity, and scarcity. Recently, liquid biopsy platforms have allowed the study of tumor‐derived materials, holding great promise for early‐stage diagnosis and monitoring of cancer when … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 172 publications
0
6
0
Order By: Relevance
“…Fourth, the plasmonic nanohole array was formed via lift-off. The design of the microchip was optimized to be compatible with integration with most existing types of microfluidic devices. , Finally, the MoSERS microchips with the size of 0.1 × 0.1 cm 2 were embedded in the fluidic sample delivery device fabricated using a 3D printing technique with a 0.2 μm filter for SERS interrogation of the circulating EVs in the patient blood samples.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Fourth, the plasmonic nanohole array was formed via lift-off. The design of the microchip was optimized to be compatible with integration with most existing types of microfluidic devices. , Finally, the MoSERS microchips with the size of 0.1 × 0.1 cm 2 were embedded in the fluidic sample delivery device fabricated using a 3D printing technique with a 0.2 μm filter for SERS interrogation of the circulating EVs in the patient blood samples.…”
Section: Methodsmentioning
confidence: 99%
“…SERS is a label-free approach that converts the entire biochemical signature of an EV, including surface chemistry and molecular cargo, into a single spectroscopic pattern, or “fingerprint” , (see Supporting Table S1). SERS is inherently noninvasive, fast, reliable, and can be adapted for use in low-resource clinical settings, especially with the emergence of hand-held instruments and fiberoptic probes. , SERS applied at an ensemble level, coupled with machine learning methods, can already differentiate between EVs in blood samples collected from healthy and diseased donors of cancers. , The working principle of SERS is based on the adsorption of analyte molecules to a plasmonic surface that allows for a strong enhancement of the Raman signal from the analyte. Nanocavities with independently tunable harmonics achieve strong electromagnetic (EM) field enhancement at distinct wavelengths .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…A great number of reviews meant that an even greater number of original research articles had been published. If we limited the results of the Scopus search to reviews related to fluids, three major fields of application emerge that attracted research interest in applying ML methods to (a) theoretical and industrial oil and gas [33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52], (b) CFD simulations [53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68], and (c) health and medical applications [69][70][71][72][73][74][75][76][77][78][79][80]…”
Section: A Brief Overview and Methods Classificationmentioning
confidence: 99%
“…Employing emerging technologies such as artificial intelligence (AI) and machine learning in the design and engineering of EV based therapeutics could be an approach to advance the research in the field. Recent studies have employed machine learning in different stages of development of EV based therapeutics including identification of EVs [166] and single EV analysis. [167][168][169] Use of above mentioned high throughput techniques such as microfluidics in combination with machine learning based EV analysis could accelerate the clinical translation of EV-based therapeutics.…”
Section: Outlook and Future Perspectivesmentioning
confidence: 99%